Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Nolan J Maloney"'
Autor:
Jasmine Rana, MD, Nolan J. Maloney, MD, Kerri E. Rieger, MD, PhD, Silvina B. Pugliese, MD, Jenna L. Strelo, MSN, RN, Anne Liu, MD, Lisa C. Zaba, MD, PhD, Bernice Y. Kwong, MD
Publikováno v:
JAAD Case Reports, Vol 13, Iss , Pp 147-151 (2021)
Externí odkaz:
https://doaj.org/article/0122a2290c6a42d2b843f642ae49957f
Publikováno v:
British Journal of Dermatology. 187:1024-1026
Publikováno v:
Journal of the American Academy of Dermatology.
Publikováno v:
Journal of the American Academy of Dermatology.
Autor:
Nolan J. Maloney, Natasha C. Zacher, Kelsey E. Hirotsu, Neil Rajan, Sumaira Z. Aasi, Nour Kibbi
Publikováno v:
Journal of the American Academy of Dermatology.
Publikováno v:
J Am Acad Dermatol
Publikováno v:
Supportive Care in Cancer. 30:2839-2851
Cutaneous reactions to BRAF inhibitors are common, but severe reactions resembling or consistent with drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) are relatively rare. Several reports sug
Autor:
Anne Y. Liu, Jasmine Rana, Lisa C. Zaba, Kerri E. Rieger, Nolan J. Maloney, Bernice Y. Kwong, Silvina Pugliese, Jenna Strelo
Publikováno v:
JAAD Case Reports
JAAD Case Reports, Vol 13, Iss, Pp 147-151 (2021)
JAAD Case Reports, Vol 13, Iss, Pp 147-151 (2021)
Publikováno v:
Journal of the American Academy of Dermatology. 87:1450-1451
Autor:
Mollie F Qian, Nicolas J Betancourt, Alain Pineda, Nolan J Maloney, Kevin A Nguyen, Sunil A Reddy, Evan T Hall, Susan M Swetter, Lisa C Zaba
Publikováno v:
The oncologist.
Background Widespread implementation of immune checkpoint inhibitors (ICI) and targeted therapies for metastatic melanoma has led to a decline in melanoma-related mortality but increased healthcare costs. We aimed to determine how healthcare utilizat